GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
Please provide your email address to receive an email when new articles are posted on . The platform allows patients and family members to compare IOL options before surgery. It simulates scenarios ...
Data around recently launched Clareon® IOL material showcases excellent vision and lasting clarity—three years after implantation1 ARGOS® Biometer with Image Guidance demonstrates significant time ...
Alcon is the leading manufacturer of intraocular lenses. Of the 20 million cataract procedures conducted globally each year, only 4% of patients receive PC-IOLs. Now, with a lens that offers a visual ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback